NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/18/2025
Back to search
Official data from USPTO
PAVBLU
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
04/25/2025
Trademark type
Word
Nice classes
5
Filing date
04/08/2022
Registration date
03/18/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/18/2025
Last transaction
04/25/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/28/2024
First use in commerce
10/28/2024
Drawing code
4
Owner type
03
Owner location
Thousand Oaks, CA
Examiner
DUBRAY, KATHERINE
Law office
M90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Amgen Inc.
Representatives
ELSA D. LEMOINE AMGEN INC.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical preparations and substances for the treatment of ophthalmic diseases and disorders
Publications
History of USPTO decisions and trademark events.
36 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/18/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/21/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/21/2025
DOCK
ASSIGNED TO EXAMINER
02/03/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/21/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/21/2025
IUAF
USE AMENDMENT FILED
11/05/2024
EISU
TEAS STATEMENT OF USE RECEIVED
11/05/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/25/2024
EX2G
SOU EXTENSION 2 GRANTED
10/25/2024
EXT2
SOU EXTENSION 2 FILED
10/25/2024
EEXT
SOU TEAS EXTENSION RECEIVED
10/25/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/16/2024
EX1G
SOU EXTENSION 1 GRANTED
04/15/2024
EXT1
SOU EXTENSION 1 FILED
04/15/2024
EEXT
SOU TEAS EXTENSION RECEIVED
04/15/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/12/2023
TMBN
TTAB RELEASE CASE TO TRADEMARKS
11/01/2023
OP.T
OPPOSITION TERMINATED NO. 999999
11/01/2023
OP.D
OPPOSITION DISMISSED NO. 999999
11/01/2023
OP.I
OPPOSITION INSTITUTED NO. 999999
09/28/2023
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
04/27/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/04/2023
PUBO
PUBLISHED FOR OPPOSITION
04/04/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/15/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/28/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/21/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/20/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/20/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/21/2022
GNRT
NON-FINAL ACTION E-MAILED
12/21/2022
CNRT
NON-FINAL ACTION WRITTEN
12/21/2022
DOCK
ASSIGNED TO EXAMINER
12/14/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/12/2022
NWAP
NEW APPLICATION ENTERED
04/12/2022
Continuous trademark protection
Get notified about every new filing that threatens PAVBLU or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.